Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on primary biliary cirrhosis.

J Heathcote1

  • 1The Toronto Western Hospital, Toronto, Canada.

Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie
|February 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathway-based analysis of primary biliary cirrhosis genome-wide association studies.

Genes and immunity·2013
Same author

Immigrant patients with chronic hepatitis C and advanced fibrosis have a higher risk of hepatocellular carcinoma.

Journal of viral hepatitis·2012
Same author

World Gastroenterology Organisation Guideline. Hepatocellular carcinoma (HCC): a global perspective.

Journal of gastrointestinal and liver diseases : JGLD·2010
Same author

Gene expression profiling of acute liver stress during living donor liver transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2006
Same author

Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice.

Alimentary pharmacology & therapeutics·2006
Same author

Twenty-four novel mutations in Wilson disease patients of predominantly European ancestry.

Human mutation·2005

Primary biliary cirrhosis (PBC) is often diagnosed before symptoms appear, with antimitochondrial antibodies as a key indicator. Ursodeoxycholic acid improves survival, while liver transplantation offers the only cure for this autoimmune liver disease.

Area of Science:

  • Hepatology
  • Autoimmunology
  • Gastroenterology

Background:

  • Primary biliary cirrhosis (PBC) is frequently diagnosed in asymptomatic individuals, sometimes preceding biochemical liver abnormalities.
  • Antimitochondrial antibodies are characteristic but not universally present, even with sensitive detection methods.
  • The exact cause of PBC is unknown, but immune-mediated interlobular bile duct destruction and associated autoimmune conditions are implicated.

Purpose of the Study:

  • To review the diagnosis, etiology, clinical presentation, and management of primary biliary cirrhosis.
  • To highlight current therapeutic strategies and their impact on patient outcomes.
  • To discuss the role of liver transplantation as a curative option.

Main Methods:

  • Literature review of primary biliary cirrhosis diagnosis and management.

Related Experiment Videos

  • Analysis of treatment efficacy, focusing on ursodeoxycholic acid and immunosuppressive therapies.
  • Evaluation of prognostic factors and outcomes, including liver transplantation.

    • Main Results:

    • Diagnosis often occurs pre-symptomatically, with antimitochondrial antibodies as a hallmark.
    • No reliable markers predict outcomes in asymptomatic PBC patients.
    • Ursodeoxycholic acid is the only treatment proven to improve survival; immunosuppressive therapies have shown limited long-term benefit.
    • Liver transplantation is the only definitive cure, with best outcomes in patients with serum bilirubin < 180 micromol/L pre-transplant.

    Conclusions:

    • Early diagnosis and management of PBC are crucial for improving patient outcomes.
    • Ursodeoxycholic acid is the cornerstone of medical therapy for PBC.
    • Liver transplantation provides a cure, with excellent survival rates when performed before significant disease progression.